These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 18375404)
1. Sweet and sour: the impact of sugars on disease. Alavi A; Axford JS Rheumatology (Oxford); 2008 Jun; 47(6):760-70. PubMed ID: 18375404 [TBL] [Abstract][Full Text] [Related]
2. The pivotal nature of sugars in normal physiology and disease. Alavi A; Axford JS Wien Med Wochenschr; 2006 Jan; 156(1-2):19-33. PubMed ID: 16465611 [TBL] [Abstract][Full Text] [Related]
3. Biological importance of glycosylation. Dwek RA Dev Biol Stand; 1998; 96():43-7. PubMed ID: 9890515 [TBL] [Abstract][Full Text] [Related]
4. Oligosaccharides: an optional extra or of relevance to disease mechanisms in rheumatology? Axford JS J Rheumatol; 1991 Aug; 18(8):1124-7. PubMed ID: 1941811 [TBL] [Abstract][Full Text] [Related]
5. Protein-glycan interactions in the control of innate and adaptive immune responses. van Kooyk Y; Rabinovich GA Nat Immunol; 2008 Jun; 9(6):593-601. PubMed ID: 18490910 [TBL] [Abstract][Full Text] [Related]
6. Influence of non HLA factors in rheumatoid arthritis: role of enzyme abnormalities in joint destruction. Perdriger A; Chalès G Rev Rhum Engl Ed; 1997 Oct; 64(10):523-6. PubMed ID: 9385687 [No Abstract] [Full Text] [Related]
7. Importance of IgG glycosylation in rheumatoid arthritis. Renaudineau Y; Saraux A; Dueymes M; Le Goff P; Youinou P Rev Rhum Engl Ed; 1998 Jun; 65(6):429-33. PubMed ID: 9670335 [No Abstract] [Full Text] [Related]
9. Terminal sugars of Fc glycans influence antibody effector functions of IgGs. Raju TS Curr Opin Immunol; 2008 Aug; 20(4):471-8. PubMed ID: 18606225 [TBL] [Abstract][Full Text] [Related]
10. Shared symptoms in rheumatic diseases: a blessing or a curse? Huizinga TW; Gröndal G Arthritis Rheum; 2009 Sep; 60(9):2547-9. PubMed ID: 19714580 [No Abstract] [Full Text] [Related]
11. Sugar-free antibodies--the bacterial solution to autoimmunity? Allhorn M; Collin M Ann N Y Acad Sci; 2009 Sep; 1173():664-9. PubMed ID: 19758213 [TBL] [Abstract][Full Text] [Related]
15. The role of nuclear factor-kappaB in the development of autoimmune diseases: a link between genes and environment. Kuryłowicz A; Nauman J Acta Biochim Pol; 2008; 55(4):629-47. PubMed ID: 19081854 [TBL] [Abstract][Full Text] [Related]
16. IgG glycosylation status as a clinical predictor of rheumatoid arthritis: comment on the article by Kim and Weisman. Isenberg DA; Young A Arthritis Rheum; 2000 Nov; 43(11):2617-8. PubMed ID: 11083296 [No Abstract] [Full Text] [Related]
17. A positive feedback loop of IL-21 signaling provoked by homeostatic CD4+CD25- T cell expansion is essential for the development of arthritis in autoimmune K/BxN mice. Jang E; Cho SH; Park H; Paik DJ; Kim JM; Youn J J Immunol; 2009 Apr; 182(8):4649-56. PubMed ID: 19342640 [TBL] [Abstract][Full Text] [Related]
18. The glycobiology of brain tumors: disease relevance and therapeutic potential. Moskal JR; Kroes RA; Dawson G Expert Rev Neurother; 2009 Oct; 9(10):1529-45. PubMed ID: 19831842 [TBL] [Abstract][Full Text] [Related]
19. Epigenetic modifications in rheumatoid arthritis. Strietholt S; Maurer B; Peters MA; Pap T; Gay S Arthritis Res Ther; 2008; 10(5):219. PubMed ID: 18947370 [TBL] [Abstract][Full Text] [Related]
20. Interleukin 21 as a target of intervention in autoimmune disease. Ettinger R; Kuchen S; Lipsky PE Ann Rheum Dis; 2008 Dec; 67 Suppl 3():iii83-6. PubMed ID: 19022821 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]